ro 31-7549 has been researched along with u 0126 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Caivano, M; Cohen, P; Davies, SP; Reddy, H | 1 |
Chen, CS; Nelson, CM | 1 |
2 other study(ies) available for ro 31-7549 and u 0126
Article | Year |
---|---|
Specificity and mechanism of action of some commonly used protein kinase inhibitors.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Acetophenones; Alkaloids; Amides; Animals; Benzamides; Benzophenanthridines; Benzopyrans; Butadienes; Cell Line; Enzyme Inhibitors; Flavonoids; Humans; Imidazoles; Indoles; Inhibitory Concentration 50; Isoquinolines; Lithium; Magnesium; Nitriles; Phenanthridines; Phosphorylation; Potassium Chloride; Protein Kinase Inhibitors; Protein Kinases; Pyridines; Sirolimus; Substrate Specificity; Sulfonamides | 2000 |
VE-cadherin simultaneously stimulates and inhibits cell proliferation by altering cytoskeletal structure and tension.
Topics: Actins; Animals; Antigens, CD; Butadienes; Cadherins; Cattle; Cell Adhesion; Cell Division; Cell Size; Cells, Cultured; Cytoskeleton; Endothelium, Vascular; Enzyme Inhibitors; Humans; Indoles; Intercellular Junctions; Maleimides; MAP Kinase Kinase Kinase 1; MAP Kinase Kinase Kinases; Microscopy, Fluorescence; Nitriles; Protein Kinase C; Signal Transduction | 2003 |